MBX Biosciences, Inc.(MBX)Earnings Date, History & Expected Move

Next report
Not scheduled

MBX has no upcoming report date in the calendar yet. It last reported on Nov 9, 2026; companies usually report every three months.

Next report
Not scheduled
Last reported Nov 9, 2026
EPS beat rate
67%
6 of 9 quarters
Avg move after earnings
±4.3%
Up 63% of the time · last 8
Options-implied move
—
No reliable options quote yet

EPS: Actual vs Estimate

Reported EPS against the consensus estimate, last 9 quarters.

Green beat or met, red missed, amber sources differ.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±4.3%).

Did the stock rise after good news?

The next-day move after each of its last 5 EPS beats and 3 misses.

When it beat expectations
5 reports
When it missed expectations
3 reports

In plain words: it beat expectations 5 times, but the stock still fell 2 of those 5 times.

Report by report
  • Nov '26
    Missed
    ▲ +4.2%
  • Aug '26
    Missed
    ▼ -0.5%
  • May '26
    Beat
    ▲ +8.1%
  • Mar '26
    Beat
    ▼ -3.4%
  • Nov '25
    Beat
    ▲ +9.7%
  • Aug '25
    Beat
    ▼ -4.6%
  • Mar '25
    Beat
    ▲ +1.7%
  • Nov '24
    Missed
    ▲ +2.1%

Clear beats and misses with a known reaction only. What counts as a beat

After an EPS beat
+2.3%
average next-day move · up 60% of 5 times
After an EPS miss
+1.9%
average next-day move · up 67% of 3 times

Why did MBX fall after beating earnings?

4 of MBX's last 8 reactions went against the EPS result. What stands out in each:

MBX beat EPS estimates in 5 quarters, and the stock still closed lower the next day 2 times.

  • Mar 12, 2026EPS beat +18.3%stock -3.4% next day
    • It opened 1.9% lower as soon as trading resumed.
  • Aug 7, 2025EPS beat +23.7%stock -4.6% next day
    • It opened 1.7% higher, but sellers took over and it closed -4.6%.

Rose despite an EPS miss (2 of 3)

  • Nov 9, 2026EPS missed -53.6%stock +4.2% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

  • Nov 7, 2024EPS missed -2.2%stock +2.1% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

Patterns in estimates and prices, not confirmed causes: how we read them.

Was MBX's earnings move already priced in?

MBX's move in the month before each of its last 8 reports, against what it did after.

Avg move in the month before
+2.1%
last 8 reports
Higher before the report
50%
of the time
After a run-up of 3%+
Fell 33%
3 reports, avg +4.5%
After a drop of 3%+
Rose 33%
3 reports, avg -2.1%

How the run-up is measured (a move of 5% or more counts as large).

Before vs after each report

Grey: the month before each of the last 8 reports. Green or red: the day after.

Past reports only. How the run-up is measured

Does MBX hold its opening gap after earnings?

MBX's opening move after each report and where it closed that day.

In 5 reports MBX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 5 times (80%), and fully reversed 2 times. Gaps up faded 2 of 2; gaps down recovered 2 of 3.

  • Nov 9, 2026Reversed
    Opened -4.7%, closed +4.2%
  • Aug 6, 2026Faded
    Opened -1.9%, closed -0.5%
  • Mar 12, 2026Held
    Opened -1.9%, closed -3.4%
  • Aug 7, 2025Reversed
    Opened +1.7%, closed -4.6%
  • Mar 17, 2025Faded
    Opened +5.7%, closed +1.7%

How gaps, fades and reversals are defined

What the history says

  • It fell after 2 of its 5 EPS beats (40%): beating estimates has not been enough on its own.

MBX earnings history

Last 9 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report dateTimeEPS est.EPS actualSurprise1-day move3-day move
Nov 9, 2026After close-$0.84-$1.29-53.6%+4.20%—
Aug 6, 2026Before open-$0.59-$0.78-32.2%-0.55%-1.97%
May 7, 2026Before open-$0.58-$0.51+12.1%+8.06%+24.78%
Mar 12, 2026Before open-$0.60-$0.49+18.3%-3.42%+2.97%
Nov 6, 2025Before open-$0.68-$0.63+7.4%+9.71%+8.60%
Aug 7, 2025Before open-$0.76-$0.58+23.7%-4.63%-3.51%
May 12, 2025Before open-$0.77-$0.71+7.8%——
Mar 17, 2025Before open-$0.59-$0.47+20.3%+1.72%-3.45%
Nov 7, 2024Before open-$2.72-$2.78-2.2%+2.07%+3.30%

MBX Earnings FAQ

Answers computed from MBX Biosciences, Inc.'s reported history

MBX has no upcoming report date in the calendar yet. It last reported on Nov 9, 2026; companies usually report every three months.

Over the last 9 quarters with a usable EPS surprise, MBX beat the consensus estimate 6 times (67%), missed 3 and landed in line 0. It has missed estimates in each of the last 2 counted quarters.

Across its last 8 quarters with a measured reaction, MBX moved an average of ±4.3% in the first session after reporting. It closed higher 63% of the time; the largest gain was 9.7% and the largest drop -4.6%.

MBX fell in the first session after 2 of its last 5 EPS beats (40%). A beat that was already priced in, or weaker guidance, can send a stock lower.

Across its last 8 quarters with price data, MBX moved an average of +2.1% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (3 quarters), it fell the next day 33% of the time, averaging +4.5%. After a drop of 3% or more (3 quarters), it rose the next day 33% of the time, averaging -2.1%. This describes past reports; it is not a forecast.

In 5 reports MBX opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 5 times (80%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.

How we calculate these numbers · MBX: 9 reported quarters, latest Nov 9, 2026. Information only, not investment advice.

Looking for more on MBX?

Price charts, forecast, fundamentals and risk pages for MBX are not on Tickzen yet. You can run a full stock analysis now.

Run the MBX Stock Analyzer